Ingrid Amalia Havnes
Biographic Data
| ID | 4226623 |
|---|---|
| NAME | Ingrid Amalia Havnes |
| GIVEN NAMES | Ingrid Amalia |
| FAMILY NAME | Havnes |
| SIGNATURE | HAVNES I A |
| AFFILIATIONS | Oslo University Hospital |
| ORCID | 0000-0002-1070-0065 |
| VERIFIED | Yes |
| TOTAL WORKS | 10 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 10 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
‘I am somebody now’—exploring meanings and experiences of gaining employment among people in substance use disorder treatment
Background Many individuals with severe Substance Use Disorders (SUD) want to work. This study explores the experiences of what gaining employment represents for patients receiving Individual Placement and Support (IPS) early in their SUD treatment.Methods Semi-structured interviews were conducted among 17 patients in specialized SUD treatment who received IPS through participating in a randomized trial. Interviews were thematically analyzed in a…
Challenges recruiting men with a desire to cease anabolic-androgenic steroid use to a pilot involving hormone therapy intervention
Introduction Long-term use of anabolic-androgenic steroids (AAS) might lead to distressing withdrawal symptoms following cessation. This paper aims to share challenges in recruiting patients to a pilot intervention study with parallel substance use disorder (SUD) treatment and to explore barriers to participation among AAS forum members.Methods Eligible AAS-dependent men were recruited to receive hormone therapy for 16 weeks, and exclusion reason…
“The compounds for females are really commonly faked!”
I go back to it every f**king time”
Introduction\nThis study addresses the dearth of research on specific anabolic-androgenic steroids (AAS), focusing on the contentious substance Trenbolone. With increased potency and risks, Trenbolone’s effects, both in animal studies and among human users, raise concerns for neurodegeneration, genotoxicity, and significant social harms. Despite these risks, people persist using Trenbolone and other AAS, navigating the harm-to-benefit ratio. The …
Patient Experiences after Physical Trauma
The coronavirus disease 2019 (COVID-19) pandemic generated a crisis within the healthcare system, during which acute, COVID-19-related health needs were prioritized over less urgent needs, including vulnerable subgroups. This study explored experiences of recovery among survivors of physical injuries associated with severe pain during the COVID-19 pandemic in Norway. In-depth interviews were conducted among 13 participants. Findings generated by …
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects
Women who use AAS are at risk of developing irreversible masculinizing effects that are difficult to process and that may negatively influence self-esteem, social life and sexual function, both during and after use. More gender-specific information about women and AAS use is needed
Factors associated with drug use in prison – results from the Norwegian offender mental health and addiction (NorMA) study
Alienation and Lack of Trust
Anabolic-androgenic steroid (AAS) use became illegal when the Norwegian Drug Act was amended in 2013, and AAS and other image- and performance-enhancing drugs were included in the politics and treatment of substance use. Few individuals with AAS-related health problems seek substance use disorder (SUD) treatment. This article aims to explore understandings of AAS dependence, barriers to treatment-seeking, and experiences of entering SUD treatment…
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Exercise is increasingly understood as an important resource for people who engage in harmful substance use, including those in prison. Little is known about how inmates adopt various health behaviors during incarceration, without interventions. This cross-sectional study analyzed self-reports from 1464 inmates in Norwegian prisons in 2013−2014, compared them according to harmful substance use pre-incarceration, and explored changes in exercise a…
Execution of control among ‘non-compliant’, imprisoned individuals in opioid maintenance treatment
No prominent works on this page.
Execution of control among ‘non-compliant’, imprisoned individuals in opioid maintenance treatment
Inmates with Harmful Substance Use Increase Both Exercise and Nicotine Use Under Incarceration
Exercise is increasingly understood as an important resource for people who engage in harmful substance use, including those in prison. Little is known about how inmates adopt various health behaviors during incarceration, without interventions. This cross-sectional study analyzed self-reports from 1464 inmates in Norwegian prisons in 2013−2014, compared them according to harmful substance use pre-incarceration, and explored changes in exercise a…
Factors associated with drug use in prison – results from the Norwegian offender mental health and addiction (NorMA) study
Alienation and Lack of Trust
Anabolic-androgenic steroid (AAS) use became illegal when the Norwegian Drug Act was amended in 2013, and AAS and other image- and performance-enhancing drugs were included in the politics and treatment of substance use. Few individuals with AAS-related health problems seek substance use disorder (SUD) treatment. This article aims to explore understandings of AAS dependence, barriers to treatment-seeking, and experiences of entering SUD treatment…
Anabolic-androgenic steroid use among women – A qualitative study on experiences of masculinizing, gonadal and sexual effects
Women who use AAS are at risk of developing irreversible masculinizing effects that are difficult to process and that may negatively influence self-esteem, social life and sexual function, both during and after use. More gender-specific information about women and AAS use is needed
Patient Experiences after Physical Trauma
The coronavirus disease 2019 (COVID-19) pandemic generated a crisis within the healthcare system, during which acute, COVID-19-related health needs were prioritized over less urgent needs, including vulnerable subgroups. This study explored experiences of recovery among survivors of physical injuries associated with severe pain during the COVID-19 pandemic in Norway. In-depth interviews were conducted among 13 participants. Findings generated by …
Challenges recruiting men with a desire to cease anabolic-androgenic steroid use to a pilot involving hormone therapy intervention
Introduction Long-term use of anabolic-androgenic steroids (AAS) might lead to distressing withdrawal symptoms following cessation. This paper aims to share challenges in recruiting patients to a pilot intervention study with parallel substance use disorder (SUD) treatment and to explore barriers to participation among AAS forum members.Methods Eligible AAS-dependent men were recruited to receive hormone therapy for 16 weeks, and exclusion reason…
“The compounds for females are really commonly faked!”
I go back to it every f**king time”
Introduction\nThis study addresses the dearth of research on specific anabolic-androgenic steroids (AAS), focusing on the contentious substance Trenbolone. With increased potency and risks, Trenbolone’s effects, both in animal studies and among human users, raise concerns for neurodegeneration, genotoxicity, and significant social harms. Despite these risks, people persist using Trenbolone and other AAS, navigating the harm-to-benefit ratio. The …
‘I am somebody now’—exploring meanings and experiences of gaining employment among people in substance use disorder treatment
Background Many individuals with severe Substance Use Disorders (SUD) want to work. This study explores the experiences of what gaining employment represents for patients receiving Individual Placement and Support (IPS) early in their SUD treatment.Methods Semi-structured interviews were conducted among 17 patients in specialized SUD treatment who received IPS through participating in a randomized trial. Interviews were thematically analyzed in a…
Psychology (9 works) · Medicine (8 works) · Psychiatry (6 works) · Hormonal and reproductive studies (5 works) · Substance use (4 works) · Anabolic-Androgenic Steroids (3 works) · Anabolism (3 works) · Computer Science (3 works) · Internal Medicine (3 works) · Sexual Differentiation and Disorders (3 works)